(Incorporated in Hong Kong with limited liability) （於香港註冊成立之有限公司） Stock Code 股份代號: 345 18th July 2025 Dear Non-registered holders (Note 1) , Vitasoy International Holdings Limited ("Company") – Notice of Publication of 2024/2025 Annual Report and 2025 AGM Circular ("Current Corporate Communications") and the 2024/2025 Sustainability Report Please be informed that the English and Chinese versions of the Company's Current Corporate Communications are available on the Company's website at www.vitasoy.com ("Com ...

(Incorporated in Hong Kong with limited liability) （於香港註冊成立之有限公司） Stock Code 股份代號: 345 18th July 2025 Dear Shareholders, Vitasoy International Holdings Limited ("Company") – Notice of Publication of 2024/2025 Annual Report and 2025 AGM Circular ("Current Corporate Communications") and the 2024/2025 Sustainability Report Please be informed that the English and Chinese versions of the Company's Current Corporate Communications are available on the Company's website at www.vitasoy.com ("Company's website") and ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本通告的內容概不負責，對其準確性或 完整性亦不發表任何聲明，並明確表示，概不對因本通告全部或任何部份內容而產生或因倚賴該 等內容而引致的任何損失承擔任何責任。 （於香港註冊成立之有限公司） （股份代號：345） 股東週年大會通告 茲通告維他奶國際集團有限公司（「本公司」）謹訂於二零二五年八月二十五日（星期一） 上午十一時正假座香港金鐘道88號太古廣場港麗酒店七樓漆咸廳舉行股東週年大會（「股東週年大 會」），議程如下： – 1 – 1. 省覽及採納截至二零二五年三月三十一日止年度經審核之財務報表及董事會與核數 師報告； 2. 批准派發截至二零二五年三月三十一日止年度之末期股息； 3. (a) 重選羅友禮先生為執行董事； (b) 重選Paul Jeremy BROUGH先生為獨立非執行董事； (c) 重選鍾志平博士為獨立非執行董事； (d) 重選容韻儀女士為獨立非執行董事； (e) 釐定董事酬金； 4. 委聘核數師及授權董事釐定核數師酬金； 5. 作為特別事項考慮及酌情通過（不論有否修訂）下列決議案為普通決議案： A. 「動議在下列條件之規限下，給予本公司董事無條 ...

此乃要件 請即處理 （於香港註冊成立之有限公司） （股份代號：345） 建議 給予一般授權以發行及購回股份、 重選董事、 向一名董事及主要股東授出購股權 及修訂章程細則及採納新章程細則 及 股東週年大會通告 本公司謹訂於二零二五年八月二十五日（星期一）上午十一時正假座香港金鐘道88號太古廣場港麗酒店七樓漆咸 廳舉行股東週年大會以考慮上述建議。召開大會之通告連同本通函寄發予股東。無論 閣下能否出席股東週年大 會，務請按照本通函隨附之代表委任表格上列印之指示填妥該表格及盡快交回，惟在任何情況下不可遲於股東週 年大會指定舉行時間四十八小時前（不包括公眾假期任何部分）（即不遲於二零二五年八月二十二日（星期五）上午 十一時正）交回。 閣下填妥及交回代表委任表格後，屆時仍可依願親身出席股東週年大會或其任何續會及投票， 在此情況下，委任代表人之文據將被視為已撤銷論。 本通函所述時間及日期均指香港時間及日期。 二零二五年七月十八日 閣下如對本通函或應採取之行動有任何疑問，應諮詢 閣下之股票經紀、銀行經理、律師、專業會計師或其他專 業顧問。 閣下如已出售或轉讓名下所有維他奶國際集團有限公司（「本公司」）之股份，應立即將本通函及 ...

可持續發展報告2024/25 股份代號 : 0345 Growing Nutrition Since 1940 | 執行主席的話 | 關於本報告 | 報告重要事項 | 維他奶及植物為本的營養 | 維他奶可持續 發展工作 | 產品組合 | | --- | --- | --- | --- | --- | --- | | 產品包裝 | 生產 | 供應鏈 | 工作環境 | 社區 | 附錄 | 2024/2025財政年度維他奶氣候與自然披露報告 目錄 | 執行主席的話 | 3 | | --- | --- | | 關於本報告 | 5 | 報告重要事項 5 2024/2025財政年度 維他奶氣候與自然披露報告 60 2 可持續發展報告2024/25 生產適當的產品 自1940年成立以來，維他奶85年來始終走在行業前列，致力於 提供價格合理且可持續的營養。作為一家領先的植物為本的食品 和飲品製造商，我們攜手廣大消費者，共同探索植物性營養的內 在益處。我們始終堅信，維他奶植物為本的產品組合「有益身體 健康」，有助於應對肥胖以及與營養不良有關的慢性疾病。 6 維他奶及植物為本的營養 9 維他奶可持續發展工作 12 生產適當的產品 ...

[Financial Highlights](index=5&type=section&id=Financial%20Highlights) [Summary of Results and Financial Position](index=5&type=page&id=Financial%20Highlights%20-%20Results%20and%20Financial%20Position) The company achieved 1% revenue growth and 102% net profit increase to HK$235 million in FY2025, driven by cost control and operational efficiency, with strong cash generation and Mainland China as the largest market Annual Performance Summary (As of March 31) | Indicator | 2025 (Million HKD) | 2024 (Million HKD) | YoY Change | | :--- | :--- | :--- | :--- | | Revenue | 6,274 | 6,217 | +1% | | Gross Profit | 3,218 | 3,111 | +3% | | EBITDA | 836 | 685 | +22% | | Net Profit Attributable to Shareholders | 235 | 116 | +102% | | Basic Earnings Per Share (HK cents) | 21.9 | 10.9 | +102% | | Total Dividend Per Ordinary Share (HK cents) | 14.2 | 7.7 | +84% | Financial Position Summary (As of March 31) | Indicator | 2025 (Million HKD) | 2024 (Million HKD) | YoY Change | | :--- | :--- | :--- | :--- | | Total Assets | 5,649 | 5,637 | Stable | | Net Cash | 657 | 111 | +492% | | Total Equity Attributable to Shareholders | 3,083 | 3,005 | +3% | - Sales analysis by region shows Mainland China as the primary revenue source, accounting for **54% of total sales**, followed by Hong Kong operations (including Hong Kong, Macau, and exports) at **36%**[30](index=30&type=chunk) [Chairman's Statement](index=7&type=section&id=Chairman%27s%20Statement) Despite market challenges, the company achieved 1% revenue growth and 102% profit increase in FY2025, driven by core market performance and operational efficiency, with a recommended total dividend of HK$14.2 cents per share [Group Chief Executive Officer's Report/Business Review](index=11&type=section&id=Group%20Chief%20Executive%20Officer%27s%20Report%2FBusiness%20Review) [Overall Business and Financial Review](index=12&type=page&id=Overall%20Business%20and%20Financial%20Review) The Group achieved 1% revenue growth and 96% operating profit increase in FY2025, driven by market improvements and efficiency gains, with gross margin at 51.3% and strong net cash of HK$657 million Revenue Growth by Key Market (in Local Currency) | Market | Revenue Growth Rate (YoY) | | :--- | :--- | | Mainland China | +1% | | Hong Kong Operations | +2% | | Australia and New Zealand | +5% | - Gross margin improved to **51.3%**, primarily due to lower raw material costs and enhanced production layout efficiency[64](index=64&type=chunk) - Operating profit significantly increased by **96%**, mainly driven by improved gross profit and strict cost control[64](index=64&type=chunk) Key Financial Indicators for FY2025 | Indicator | 2025 | 2024 | Change | | :--- | :--- | :--- | :--- | | Revenue (Million HKD) | 6,274 | 6,217 | +1% | | Net Profit Attributable to Shareholders (Million HKD) | 235 | 116 | +102% | | Basic Earnings Per Share (HK cents) | 21.9 | 10.9 | +102% | | Gearing Ratio | 20% | 23% | -3 percentage points | | Return on Capital Employed (ROCE) | 25% | 21% | +4 percentage points | - As of March 31, 2025, the Group's cash and bank balances were **HK$1.268 billion**, with net cash (after deducting borrowings, bills payable, and lease liabilities) at **HK$657 million**, a significant increase from **HK$111 million** in the prior year[128](index=128&type=chunk) [Review of operations](index=21&type=page&id=Review%20of%20operations) Key markets showed varied performance, with Mainland China and Hong Kong achieving revenue and profit growth, while Australia/New Zealand and Singapore narrowed operating losses [Mainland China](index=21&type=page&id=Mainland%20China) Mainland China achieved 1% revenue growth and a significant 41% increase in operating profit to RMB289 million, driven by core product performance and efficiency gains Mainland China Operations Financial Performance | Indicator | 2025 | 2024 | YoY Change | | :--- | :--- | :--- | :--- | | Revenue from External Customers (Million RMB) | 3,116 | 3,087 | +1% | | Operating Profit (Million RMB) | 289 | 203 | +42% | | Revenue from External Customers (Million HKD) | 3,363 | 3,359 | Stable | | Operating Profit (Million HKD) | 311 | 221 | +41% | [Hong Kong Operation](index=22&type=page&id=Hong%20Kong%20Operation) Hong Kong operations achieved 2% revenue growth and 24% operating profit increase to HK$279 million, driven by sales volume and cost reductions despite a challenging retail environment Hong Kong Operations Financial Performance | Indicator (Million HKD) | 2025 | 2024 | YoY Change | | :--- | :--- | :--- | :--- | | Revenue from External Customers | 2,261 | 2,224 | +2% | | Operating Profit | 279 | 225 | +24% | [Australia and New Zealand](index=23&type=page&id=Australia%20and%20New%20Zealand) Australia and New Zealand revenue grew 5% in local currency, with full-year operating loss narrowing by 4% to A$15 million due to production stability and logistics optimization Australia and New Zealand Operations Financial Performance | Indicator | 2025 | 2024 | YoY Change | | :--- | :--- | :--- | :--- | | Revenue from External Customers (Million AUD) | 107 | 103 | +5% | | Operating Loss (Million AUD) | (15) | (16) | +4% | | Revenue from External Customers (Million HKD) | 544 | 527 | +3% | | Operating Loss (Million HKD) | (77) | (81) | +5% | [Singapore](index=24&type=page&id=Singapore) Singapore market revenue slightly decreased by 1%, but operating loss narrowed by 40% due to lower raw material costs and optimized sales mix, despite distributor changes affecting imported beverages Singapore Operations Financial Performance | Indicator | 2025 | 2024 | YoY Change | | :--- | :--- | :--- | :--- | | Revenue from External Customers (Thousand SGD) | 18,223 | 18,396 | -1% | | Operating Loss (Thousand SGD) | (1,327) | (2,210) | +40% | | Revenue from External Customers (Thousand HKD) | 106,131 | 107,008 | -1% | | Operating Loss (Thousand HKD) | (7,729) | (12,855) | +40% | [Business Outlook](index=24&type=page&id=Business%20Outlook) The company aims to maintain business scale and profitability by expanding core categories, especially in Mainland China, while reducing losses in Australia, confident in long-term growth opportunities - Mainland China: Short-term goal is to maintain business scale and profitability, enhancing per-store sales and product availability through strengthened sales execution[174](index=174&type=chunk)[179](index=179&type=chunk) - Hong Kong: Will continue to execute expansion strategies to sustain high-margin revenue growth, with minimal expected tariff impact on US export business (<2%)[175](index=175&type=chunk)[180](index=180&type=chunk) - Australia and New Zealand: Leveraging stabilized production operations to accelerate sales, continuing to reduce operating losses through innovation and improved operational efficiency[176](index=176&type=chunk)[181](index=181&type=chunk) - Philippines: The joint venture with Universal Robina Corporation will continue to scale up, investing in a comprehensive product portfolio of soy milk, almond milk, and oat milk[178](index=178&type=chunk)[183](index=183&type=chunk) [Corporate Governance Report](index=27&type=section&id=Corporate%20Governance%20Report) The report details the company's adherence to high corporate governance standards in FY2025, covering board structure, committee functions, risk management, and internal controls, ensuring transparency and accountability [Board of Directors](index=31&type=page&id=Board%20of%20Directors) The diverse Board of Directors, with 40% independent non-executive members, oversees strategy, held five meetings with 95% attendance, and conducted annual assessments to enhance effectiveness Board Composition Diversity Overview | Category | Breakdown | Quantity/Ratio | | :--- | :--- | :--- | | **Function** | Independent Non-Executive Directors | 4 | | | Non-Executive Directors | 3 | | | Executive Directors | 3 | | **Gender** | Female | 3 (30%) | | | Male | 7 (70%) | | **Age** | Over 70 | 4 | | | 61-70 | 4 | | | 51-60 | 1 | | | 41-50 | 1 | - Board members possess diverse core skills, professional knowledge, and experience, covering general management, accounting and audit, legal, food technology, marketing, and production project management, ensuring effective board performance[229](index=229&type=chunk)[230](index=230&type=chunk) - The company has achieved its board diversity targets: female representation is **30.0%**, exceeding the "not less than 18%" target; the average age of board members is **66 years**, meeting the "average 67 years" target[237](index=237&type=chunk)[238](index=238&type=chunk) [Board Committees](index=46&type=page&id=Board%20Committees) The Board's committees (Remuneration & Nomination, Audit, ESG, Executive) have clear mandates, with independent non-executive chairs ensuring oversight of compensation, financial reporting, and sustainability - The Remuneration and Nomination Committee is responsible for reviewing executive compensation, board structure and diversity, assessing the independence of independent non-executive directors, and making recommendations on director appointments and succession planning to the Board[288](index=288&type=chunk)[290](index=290&type=chunk) - The Audit Committee oversees the financial reporting process, appointment and coordination of internal and external auditors, evaluates the effectiveness of risk management and internal control systems, and reviews the company's compliance and whistleblowing policies[297](index=297&type=chunk)[299](index=299&type=chunk) - The Environmental, Social and Governance (ESG) Committee is responsible for providing guidance on the Group's sustainability objectives, strategies, and progress, reviewing ESG-related risks and opportunities, and approving the company's sustainability report[313](index=313&type=chunk)[315](index=315&type=chunk) [Risk Management and Internal Control](index=69&type=page&id=Risk%20Management%20and%20Internal%20Control) The company maintains a comprehensive COSO-based risk management and internal control system, overseen by the Board and Audit Committee, with independent internal audit and ethical policies - The company's risk governance structure is divided into three levels: oversight (Audit Committee, Group Internal Audit), risk monitoring and review (Enterprise Risk Management Executive Committee, local company CEOs, Group Risk Management Department), and risk and control responsibility (department heads and employees)[408](index=408&type=chunk)[411](index=411&type=chunk)[413](index=413&type=chunk) - The risk management process includes six stages: Anticipate, Rate, Respond, Regulate, React, and Report[414](index=414&type=chunk)[418](index=418&type=chunk) - The Board, confirmed by management, considers the risk management and internal control systems for the year ended March 31, 2025, to be effective and adequate, with no significant issues identified that could affect the company's financial, operational, compliance, and risk management functions[424](index=424&type=chunk) [Report of the Directors](index=96&type=section&id=Report%20of%20the%20Directors) The Report of the Directors covers business activities, financial performance, and governance, including a recommended total annual dividend of HK$14.0 cents per share and details on share schemes and buybacks [Dividends, Share Capital and Buy-backs](index=97&type=page&id=Dividends%2C%20Share%20Capital%20and%20Buy-backs) The company paid an interim dividend of HK$4.0 cents and recommended a final dividend of HK$10.2 cents, while repurchasing 4,232,000 shares for HK$40.45 million - The Board recommended a final dividend of **HK$10.2 cents** per ordinary share for the year ended March 31, 2025, bringing the total annual dividend to **HK$14.2 cents** including the interim dividend of HK$4.0 cents already paid[514](index=514&type=chunk) Share Buyback Details (March 2025) | Number of Shares Repurchased (Thousands) | Highest Price Per Share (HKD) | Lowest Price Per Share (HKD) | Total Consideration (Excluding Expenses, Thousand HKD) | | :--- | :--- | :--- | :--- | | 4,232 | 10.00 | 9.08 | 40,449 | - During the year, the trustee of the company's 2021 Share Award Scheme purchased a total of **1,300,000** company shares on the Stock Exchange for a total consideration of approximately **HK$7.6 million** to satisfy share awards to participants[642](index=642&type=chunk) [Equity-linked Agreements](index=101&type=page&id=Equity-linked%20Agreements) The company operates 2022 Share Option and 2021 Share Award Schemes, with 9.22% of issued shares available for grant, and details unexercised options and unvested awards - As of March 31, 2025, there were a total of **19,411,000** unexercised share options under the 2012 and 2022 Share Option Schemes[570](index=570&type=chunk)[574](index=574&type=chunk) - As of March 31, 2025, there were a total of **4,470,474** unvested award shares under the 2021 Share Award Scheme[590](index=590&type=chunk) [Consolidated Financial Statements](index=125&type=section&id=Consolidated%20Financial%20Statements) [Consolidated Statement of Profit or Loss](index=125&type=page&id=Consolidated%20Statement%20of%20Profit%20or%20Loss) The Group's revenue grew 1% to HK$6.274 billion, with operating profit surging to HK$364 million and profit attributable to shareholders increasing 102% to HK$235 million Consolidated Statement of Profit or Loss Summary | Item (Thousand HKD) | 2025 | 2024 | | :--- | :--- | :--- | | Revenue | 6,273,585 | 6,217,123 | | Gross Profit | 3,217,546 | 3,111,437 | | Operating Profit | 363,575 | 185,432 | | Profit Before Tax | 316,990 | 131,668 | | Profit for the Year | 240,568 | 117,788 | | **Profit Attributable to Shareholders** | **234,674** | **116,367** | | Basic Earnings Per Share (HK cents) | 21.9 | 10.9 | [Consolidated Statement of Financial Position](index=128&type=page&id=Consolidated%20Statement%20of%20Financial%20Position) As of March 31, 2025, total assets were stable at HK$5.649 billion, total liabilities decreased, and net assets attributable to shareholders increased 3% to HK$3.083 billion Consolidated Statement of Financial Position Summary | Item (Thousand HKD) | March 31, 2025 | March 31, 2024 | | :--- | :--- | :--- | | **Total Assets** | **5,648,700** | **5,636,695** | | Non-Current Assets | 3,023,166 | 3,389,625 | | Current Assets | 2,625,534 | 2,247,070 | | **Total Liabilities** | **2,466,518** | **2,524,058** | | Current Liabilities | 2,141,985 | 2,225,376 | | Non-Current Liabilities | 324,533 | 298,682 | | **Net Assets** | **3,182,182** | **3,112,637** | | Total Equity Attributable to Shareholders | 3,083,158 | 3,004,560 | [Consolidated Cash Flow Statement](index=132&type=page&id=Consolidated%20Cash%20Flow%20Statement) Net cash from operations increased to HK$859 million, investing activities turned to a net inflow of HK$65.89 million, leading to a net increase of HK$627 million in cash and cash equivalents Consolidated Cash Flow Statement Summary | Item (Thousand HKD) | 2025 | 2024 | | :--- | :--- | :--- | | Net Cash from Operating Activities | 859,017 | 790,543 | | Net Cash from/(used in) Investing Activities | 65,893 | (294,294) | | Net Cash used in Financing Activities | (298,236) | (403,493) | | **Net Increase in Cash and Cash Equivalents** | **626,674** | **92,756** | | Cash and Cash Equivalents at Beginning of Period | 642,954 | 554,785 | | **Cash and Cash Equivalents at End of Period** | **1,268,475** | **642,954** | [Five Year Summary](index=260&type=section&id=Five%20Year%20Summary) The five-year summary shows revenue stabilizing around HK$6.2-6.3 billion, with operating profit and shareholder-attributable profit recovering significantly after a FY2022 loss, and basic EPS at HK$21.9 cents [Five Year Financial Summary](index=260&type=page&id=Five%20Year%20Financial%20Summary) This section provides a tabular overview of the company's core financial indicators for the past five fiscal years, illustrating long-term performance trends and financial position changes Five Year Performance Summary (Million HKD) | Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 | | :--- | :--- | :--- | :--- | :--- | :--- | | Revenue | 6,274 | 6,217 | 6,341 | 6,501 | 7,520 | | Operating Profit/(Loss) | 364 | 185 | 104 | (213) | 843 | | Profit/(Loss) Attributable to Shareholders | 235 | 116 | 46 | (159) | 548 | Five Year Assets and Liabilities Summary (Million HKD) | Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 | | :--- | :--- | :--- | :--- | :--- | :--- | | Total Assets Less Current Liabilities | 3,507 | 3,411 | 3,378 | 3,776 | 4,192 | | Net Assets | 3,182 | 3,113 | 3,101 | 3,569 | 3,957 |

Core Insights - The beverage industry is facing intense competition, leading to challenges and uncertainties. The CEO of Vitasoy China, Wang Dong, has shared insights from his first year in the role, highlighting the company's performance and strategic direction [1] Financial Performance - Vitasoy International reported a revenue of HKD 6.274 billion for the fiscal year 2024/2025, representing a year-on-year growth of 1%. Net profit reached HKD 235 million, a significant increase of 102% [2] - The growth was primarily driven by improvements in the mainland China business, which saw a revenue increase of 1% and a 41% rise in operating profit, alongside strong performance in the Hong Kong market with a 24% increase in operating profit [2] - The company's gross profit margin improved to 51.3%, attributed to optimized procurement, enhanced operational efficiency, and cost control measures [2] Strategic Focus - Wang Dong emphasized the importance of stable business scale and recovery growth as key drivers for sustainable profit development. The company has systematically optimized internal management processes and operational efficiency, particularly in sales forecasting, production planning, and logistics management [2] - The company aims to continue enhancing operational efficiency and reducing raw material costs to further improve profitability [4] Pricing Strategy - Vitasoy has adjusted its pricing strategy to align with mainstream market levels, moving away from previously higher price points. Wang Dong clarified that the company will not engage in price wars that compromise product quality, instead opting for high-quality offerings in the premium price segment [4] - The company recognizes the complexity of consumer price perception, which varies significantly across different purchasing channels and usage scenarios [4] Product Development and Consumer Trends - Vitasoy has been actively innovating its product offerings, introducing new flavors and formats to meet evolving consumer preferences. Successful products include the Duck Shit Lemon Tea and White Peach Soy Milk, which were developed based on deep consumer insights [5][8] - The company is responding to a trend of increasing health consciousness among consumers, who are seeking personalized and diverse beverage options. This includes a growing interest in sugar-free teas and wellness-focused products [8] - Vitasoy's channel strategy is crucial in the rapidly evolving Chinese market, focusing on high-traffic and popular channels to align with consumer demand and shopping behaviors [8]

1 根據上市規則第 17.04(1)條，向羅先生、陸先生及黎先生授出購股權已由本公司獨 立非執行董事審閲及批准。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 （於香港註冊成立之有限公司） （股份代號：345） 有關授出購股權及績效股份單位之補充公告 本公告乃根據香港聯合交易所有限公司證券上市規則（「上市規則」）第 17.06A、 17.06B 及 17.06C 條而作出。 茲提述維他奶國際集團有限公司（「本公司」，連同其附屬公司（「附屬公 司」），統稱「本集團」）日期為二零二五年六月三十日有關授出購股權及績效股 份單位之公告（「該公告」）。除文義另有所指外，本公告之詞彙與該公告所界定 者具有相同涵義。 誠如該公告所載，在授出之全部 4,912,000 份購股權中，1,326,000 份購股權授予 羅友禮先生（本公司執行主席及主要股東），1,206,000 份購股權授予陸博濤先生 （本公司執行董事兼集團行政總裁），88,000 份購股權授予黎中山先 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 維他奶國際集團有限公司 呈交日期： 2025年7月10日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 普通股 | | 股份類別 不適用 | | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) 00345 | | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 事件 | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | 每股發行/出售價 (註4) | | 已發 ...

公司名稱： 維他奶國際集團有限公司 呈交日期： 2025年7月9日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00345 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | ...